These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 28681696)
1. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression. Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696 [TBL] [Abstract][Full Text] [Related]
2. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues. Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689 [TBL] [Abstract][Full Text] [Related]
3. MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans. Briggs MT; Condina MR; Ho YY; Everest-Dass AV; Mittal P; Kaur G; Oehler MK; Packer NH; Hoffmann P Proteomics; 2019 Nov; 19(21-22):e1800482. PubMed ID: 31364262 [TBL] [Abstract][Full Text] [Related]
5. Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics. Zhang X; Wang Y; Qian Y; Wu X; Zhang Z; Liu X; Zhao R; Zhou L; Ruan Y; Xu J; Liu H; Ren S; Xu C; Gu J PLoS One; 2014; 9(2):e87978. PubMed ID: 24516574 [TBL] [Abstract][Full Text] [Related]
6. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. Hua S; Williams CC; Dimapasoc LM; Ro GS; Ozcan S; Miyamoto S; Lebrilla CB; An HJ; Leiserowitz GS J Chromatogr A; 2013 Mar; 1279():58-67. PubMed ID: 23380366 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288 [TBL] [Abstract][Full Text] [Related]
8. Differential N-glycan patterns identified in lung adenocarcinoma by N-glycan profiling of formalin-fixed paraffin-embedded (FFPE) tissue sections. Wang X; Deng Z; Huang C; Zhu T; Lou J; Wang L; Li Y J Proteomics; 2018 Feb; 172():1-10. PubMed ID: 29157724 [TBL] [Abstract][Full Text] [Related]
9. Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma. Anugraham M; Jacob F; Everest-Dass AV; Schoetzau A; Nixdorf S; Hacker NF; Fink D; Heinzelmann-Schwarz V; Packer NH Mol Oncol; 2017 Nov; 11(11):1595-1615. PubMed ID: 28853212 [TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry Imaging of N-Glycans from Formalin-Fixed Paraffin-Embedded Tissue Sections Using a Novel Subatmospheric Pressure Ionization Source. Shi Y; Li Z; Felder MA; Yu Q; Shi X; Peng Y; Cao Q; Wang B; Puglielli L; Patankar MS; Li L Anal Chem; 2019 Oct; 91(20):12942-12947. PubMed ID: 31507162 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis. Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355 [TBL] [Abstract][Full Text] [Related]
12. N-glycomic profiling as a tool to separate rectal adenomas from carcinomas. Kaprio T; Satomaa T; Heiskanen A; Hokke CH; Deelder AM; Mustonen H; Hagström J; Carpen O; Saarinen J; Haglund C Mol Cell Proteomics; 2015 Feb; 14(2):277-88. PubMed ID: 25452313 [TBL] [Abstract][Full Text] [Related]
14. The ascites N-glycome of epithelial ovarian cancer patients. Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862 [TBL] [Abstract][Full Text] [Related]
15. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy. Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294 [TBL] [Abstract][Full Text] [Related]
16. Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells. Guo J; Li X; Tan Z; Lu W; Yang G; Guan F Molecules; 2014 Dec; 19(12):20073-90. PubMed ID: 25470275 [TBL] [Abstract][Full Text] [Related]
17. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression. Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799 [TBL] [Abstract][Full Text] [Related]
18. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status. Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH Mol Cell Proteomics; 2014 Sep; 13(9):2213-32. PubMed ID: 24855066 [TBL] [Abstract][Full Text] [Related]
19. Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis. Amin A; Bashir A; Zaki N; McCarthy D; Ahmed S; Lotfy M World J Gastroenterol; 2015 May; 21(20):6167-79. PubMed ID: 26034352 [TBL] [Abstract][Full Text] [Related]
20. N-glycomic profiling of colorectal cancer according to tumor stage and location. Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C PLoS One; 2020; 15(6):e0234989. PubMed ID: 32598367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]